Top

Published in:

01-06-2018 | Original Paper

Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam

Authors: Wataru Ochiai, Hiroko Kobayashi, Satoshi Kitaoka, Mayumi Kashiwada, Yuya Koyama, Saho Nakaishi, Tomomi Nagai, Masaki Aburada, Kiyoshi Sugiyama

Published in: Journal of Natural Medicines | Issue 3/2018

Abstract

5,7-Dimethoxyflavone (5,7-DMF), one of the major components of Kaempferia parviflora, has anti-obesity, anti-inflammatory, and antineoplastic effects. On the other hand, in vitro studies have reported that it directly inhibits the drug metabolizing enzyme family cytochrome P450 (CYP) 3As. In this study, its safety was evaluated from a pharmacokinetic point of view, based on daily ingestion of 5,7-DMF. Midazolam, a substrate of CYP3As, was orally administered to mice treated with 5,7-DMF for 10 days, and its pharmacokinetic properties were investigated. In the group administered 5,7-DMF, the area under the curve (AUC) of midazolam increased by 130% and its biological half-life was extended by approximately 100 min compared to the control group. Compared to the control group, 5,7-DMF markedly decreased the expression of CYP3A11 and CYP3A25 in the liver. These results suggest that continued ingestion of 5,7-DMF decreases the expression of CYP3As in the liver, consequently increasing the blood concentrations of drugs metabolized by CYP3As.

Saokaew S, Wilairat P, Raktanyakan P, Dilokthornsakul P, Dhippayom T, Kongkaew C, Sruamsiri R, Chuthaputti A, Chaiyakunapruk N (2016) Clinical effects of Krachaidum (Kaempferia parviflora): a systematic review. J Evid Based Complementary Altern Med. https://doi.org/10.1177/2156587216669628 CrossRefPubMedPubMedCentral

Potikanond S, Sookkhee S, Na Takuathung M, Mungkornasawakul P, Wikan N, Smith DR, Nimlamool W (2017) Kaempferia parviflora extract exhibits anti-cancer activity against HeLa cervical cancer cells. Front Pharmacol 8:630CrossRef

Sawasdee P, Sabphon C, Sitthiwongwanit D, Kokpol U (2009) Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora. Phytother Res 23:1792–1794CrossRef

Kobayashi H, Suzuki R, Sato K, Ogami T, Tomozawa H, Tsubata M, Ichinose K, Aburada M, Ochiai W, Sugiyama K, Shimada T (2017) Effect of Kaempferia parviflora extract on knee osteoarthritis. J Nat Med. https://doi.org/10.1007/s11418-017-1121-6 CrossRefPubMed

Wattanapitayakul SK, Suwatronnakorn M, Chularojmontri L, Herunsalee A, Niumsakul S, Charuchongkolwongse S, Chansuvanich N (2007) Kaempferia parviflora ethanolic extract promoted nitric oxide production in human umbilical vein endothelial cells. J Ethnopharmacol 110:559–562CrossRef

Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Chansuvanich N (2008) Vasorelaxation and antispasmodic effects of Kaempferia parviflora ethanolic extract in isolated rat organ studies. Fitoterapia 79:214–216CrossRef

Tewtrakul S, Subhadhirasakul S, Kummee S (2008) Anti-allergic activity of compounds from Kaempferia parviflora. J Ethnopharmacol 116:191–193CrossRef

Rujjanawate C, Kanjanapothi D, Amornlerdpison D, Pojanagaroon S (2005) Anti-gastric ulcer effect of Kaempferia parviflora. J Ethnopharmacol 102:120–122CrossRef

Mekjaruskul C, Sripanidkulchai B (2015) Pharmacokinetic interaction between Kaempferia parviflora extract and sildenafil in rats. J Nat Med 69:224–231CrossRef

10.

Akase T, Shimada T, Terabayashi S, Ikeya Y, Sanada H, Aburada M (2011) Antiobesity effects of Kaempferia parviflora in spontaneously obese type II diabetic mice. J Nat Med 65:73–80CrossRef

11.

Horikawa T, Shimada T, Okabe Y, Kinoshita K, Koyama K, Miyamoto K, Ichinose K, Takahashi K, Aburada M (2012) Polymethoxyflavonoids from Kaempferia parviflora induce adipogenesis on 3T3-L1 preadipocytes by regulating transcription factors at an early stage of differentiation. Biol Pharm Bull 35:686–692CrossRef

12.

Kobayashi H, Horiguchi-Babamoto E, Suzuki M, Makihara H, Tomozawa H, Tsubata M, Shimada T, Sugiyama K, Aburada M (2016) Effects of ethyl acetate extract of Kaempferia parviflora on brown adipose tissue. J Nat Med 70:54–61CrossRef

13.

Matsushita M, Yoneshiro T, Aita S, Kamiya T, Kusaba N, Yamaguchi K, Takagaki K, Kameya T, Sugie H, Saito M (2015) Kaempferia parviflora extract increases whole-body energy expenditure in humans: roles of brown adipose tissue. J Nutr Sci Vitaminol (Tokyo) 61:79–83CrossRef

14.

Okabe Y, Shimada T, Horikawa T, Kinoshita K, Koyama K, Ichinose K, Aburada M, Takahashi K (2014) Suppression of adipocyte hypertrophy by polymethoxyflavonoids isolated from Kaempferia parviflora. Phytomedicine 21:800–806CrossRef

15.

Shimada T, Horikawa T, Ikeya Y, Matsuo H, Kinoshita K, Taguchi T, Ichinose K, Takahashi K, Aburada M (2011) Preventive effect of Kaempferia parviflora ethyl acetate extract and its major components polymethoxyflavonoid on metabolic diseases. Fitoterapia 82:1272–1278CrossRef

16.

Yoshino S, Kim M, Awa R, Kuwahara H, Kano Y, Kawada T (2014) Kaempferia parviflora extract increases energy consumption through activation of BAT in mice. Food Sci Nutr 2:634–637CrossRef

17.

Toda K, Hitoe S, Takeda S, Shimoda H (2016) Black ginger extract increases physical fitness performance and muscular endurance by improving inflammation and energy metabolism. Heliyon 2:e00115CrossRef

18.

Welbat JU, Chaisawang P, Chaijaroonkhanarak W, Prachaney P, Pannangrong W, Sripanidkulchai B, Wigmore P (2016) Kaempferia parviflora extract ameliorates the cognitive impairments and the reduction in cell proliferation induced by valproic acid treatment in rats. Ann Anat 206:7–13CrossRef

19.

Park JE, Woo SW, Kim MB, Kim C, Hwang JK (2017) Standardized Kaempferia parviflora extract inhibits intrinsic aging process in human dermal fibroblasts and hairless mice by inhibiting cellular senescence and mitochondrial dysfunction. Evid Based Complementary Altern Med 2017:6861085

20.

Li H, Zhang X, Wang W (2017) Anticancer activity of 5, 7-dimethoxyflavone against liver cancer cell line HEPG2 involves apoptosis, ROS generation and cell cycle arrest. Afr J Tradit Complement Altern Med 14:213–220CrossRef

21.

Song Y, Kim MB, Kim C, Kim J, Hwang JK (2016) 5,7-Dimethoxyflavone attenuates obesity by inhibiting adipogenesis in 3T3-L1 adipocytes and high-fat diet-induced obese C57BL/6J mice. J Med Food 19:1111–1119CrossRef

22.

Mekjaruskul C, Jay M, Sripanidkulchai B (2012) Modulatory effects of Kaempferia parviflora extract on mouse hepatic cytochrome P450 enzymes. J Ethnopharmacol 141:831–839CrossRef

23.

Walle UK, Walle T (2007) Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. Drug Metab Dispos 35:1985–1989CrossRef

24.

Anakk S, Kalsotra A, Kikuta Y, Huang W, Zhang J, Staudinger JL, Moore DD, Strobel HW (2004) CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J 4:91–101CrossRef

25.

Yang J, Hao C, Yang D, Shi D, Song X, Luan X, Hu G, Yan B (2010) Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes. Toxicol Lett 197:219–226CrossRef

26.

Ghosal A, Satoh H, Thomas PE, Bush E, Moore D (1996) Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. Drug Metab Dispos 24:940–947PubMed

27.

Maenpaa J, Hall SD, Ring BJ, Strom SC, Wrighton SA (1998) Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. Pharmacogenetics 8:137–155PubMed

28.

Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ (1985) Midazolam: pharmacology and uses. Anesthesiology 62:310–324CrossRef

29.

Bei D, An G (2016) Pharmacokinetics and tissue distribution of 5,7-dimethoxyflavone in mice following single dose oral administration. J Pharm Biomed Anal 119:65–70CrossRef

30.

Hisaka A, Sugiyama Y (1998) Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method. J Pharmacokinet Biopharm 26:495–519CrossRef

31.

Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1–18CrossRef

32.

Li Y, Cui Y, Hart SN, Klaassen CD, Zhong XB (2009) Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol 75:1171–1179CrossRef

33.

Sakuma T, Takai M, Endo Y, Kuroiwa M, Ohara A, Jarukamjorn K, Honma R, Nemoto N (2000) A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Arch Biochem Biophys 377:153–162CrossRef

34.

Dai D, Bai R, Hodgson E, Rose RL (2001) Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6beta-hydroxylase. J Biochem Mol Toxicol 15:90–99CrossRef

35.

Peng L, Yoo B, Gunewardena SS, Lu H, Klaassen CD, Zhong XB (2012) RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development. Drug Metab Dispos 40:1198–1209CrossRef

36.

Kitaoka S, Hatogai J, Iimura R, Yamamoto Y, Oba K, Nakai M, Kusunoki Y, Ochiai W, Sugiyama K (2018) Relationship between low midazolam metabolism by cytochrome P450 3A in mice and the high incidence of birth defects. J Toxicol Sci 43:65–74CrossRef

37.

Zhao M, Xiaofei L, Gang C, Wei L, Jing X, Gang H, Ruini C, Rui N, Wei S, Jian Y, Bingfang Y (2012) DEC1 binding to the proximal promoter of CYP3A4 ascribes to the downregulation of CYP3A4 expression by IL-6 in primary human hepatocytes. Biochem Pharmacol 84:701–711CrossRef

Title: Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam
Authors: Wataru Ochiai
Hiroko Kobayashi
Satoshi Kitaoka
Mayumi Kashiwada
Yuya Koyama
Saho Nakaishi
Tomomi Nagai
Masaki Aburada
Kiyoshi Sugiyama
Publication date: 01-06-2018
Publisher: Springer Singapore
Published in: Journal of Natural Medicines / Issue 3/2018
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-018-1184-z

At a glance: The STEP trials

Springer Medicine

Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production

Toosendanin mediates cisplatin sensitization through targeting Annexin A4/ATP7A in non-small cell lung cancer cells

Greetings from the chief editor

A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells

Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway

Anti-invasive effect of Cyclamen pseudibericum extract on A549 non-small cell lung carcinoma cells via inhibition of ZEB1 mediated by miR-200c